Pancancer landscape analysis of the thymosin family identified TMSB10 as a potential prognostic biomarker and immunotherapy target in glioma.
Cancer Cell Int
; 22(1): 294, 2022 Sep 26.
Article
en En
| MEDLINE
| ID: mdl-36163046
Texto completo:
1
Base de datos:
MEDLINE
Tipo de estudio:
Prognostic_studies
Idioma:
En
Revista:
Cancer Cell Int
Año:
2022
Tipo del documento:
Article